Versigent CLO granted 113 dividend rights

Versigent’s CLO and Secretary received a small dividend-equivalent rights award tied to existing restricted stock units, with no open-market trading involved.

Rhea-AI Filing Summary

Versigent PLC (symbol: VGNT) is the issuer of record for a Form 4 filing submitted to the SEC. Acosta Janis N reported acquisition or exercise transactions in this Form 4 filing.

Versigent PLC (VGNT) reported that its CLO and Secretary, Janis N. Acosta, received an award of 113.023 dividend equivalent rights on September 18, 2026. These rights accrued on her restricted stock units due to a cash dividend and are the economic equivalent of 113.023 ordinary shares, vesting on the same schedule as the related units. After this award, she directly holds 113.023 dividend equivalent rights, and no Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Grant/Award: 113.023 shares

Grant/Award 1 txn

Insider Acosta Janis N

Role CLO and Secretary

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights F1	113.023	$0.00	$0.00

Holdings After Transaction: Dividend Equivalent Rights — 113.023 contracts (Direct)

Footnotes (1)

1. F1. The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares.

Key Figures

Dividend equivalent rights granted: 113.023 rights Underlying ordinary shares: 113.023 shares Transaction price per right: $0.00 per right +1 more

4 metrics

Dividend equivalent rights granted 113.023 rights Award to CLO and Secretary Janis N. Acosta on September 18, 2026

Underlying ordinary shares 113.023 shares Each dividend equivalent right is the economic equivalent of one ordinary share

Transaction price per right $0.00 per right Reported transaction price for the grant of dividend equivalent rights

Total dividend equivalent rights held after transaction 113.023 rights Direct holdings of dividend equivalent rights following the September 18, 2026 award

Key Terms

Dividend Equivalent Rights, restricted stock units, economic equivalent

3 terms

Dividend Equivalent Rights financial

"The dividend equivalent rights accrued on grants of restricted stock units"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

restricted stock units financial

"The dividend equivalent rights accrued on grants of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

economic equivalent financial

"Each dividend equivalent right is the economic equivalent of one share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Versigent PLC (VGNT) report for Janis N. Acosta?

Versigent reported that CLO and Secretary Janis N. Acosta received a grant of 113.023 dividend equivalent rights on September 18, 2026, as a derivative award related to her existing restricted stock units, with no cash price per right stated.

How many dividend equivalent rights were granted to the Versigent (VGNT) officer and at what price?

Janis N. Acosta was granted 113.023 dividend equivalent rights at a reported transaction price of $0.00 per right. The rights accrued automatically from a dividend declared and paid on Versigent’s ordinary shares in respect of her restricted stock units.

What are the dividend equivalent rights reported by Versigent (VGNT) in this Form 4?

The filing states that each dividend equivalent right is the economic equivalent of one ordinary share of Versigent PLC. They accrue on restricted stock units when a dividend is declared and are designed to mirror the dividend value on the underlying shares.

When do the Versigent (VGNT) dividend equivalent rights for Janis N. Acosta vest?

According to the filing, the dividend equivalent rights vest on the same schedule as the restricted stock units to which they relate. No separate vesting schedule is provided for the dividend equivalent rights themselves.

Did Versigent’s CLO and Secretary trade ordinary shares in this Form 4 transaction?

No. The transaction reported is an award of dividend equivalent rights, a derivative linked to ordinary shares. There is no reported open-market purchase or sale of Versigent’s ordinary shares in this Form 4.

Was the Versigent (VGNT) Form 4 transaction made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that no Rule 10b5-1 trading plan is reported for this transaction. It reflects an automatic accrual of dividend equivalent rights from a dividend paid on the issuer’s ordinary shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/22/2026 - 04:03 PM Accepted by SEC EDGAR 09/22/2026 - 04:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Acosta Janis N

(Last) (First) (Middle)

SPITALSTRASSE 5,

(Street)

8200 SCHAFFHAUSEN

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Versigent PLC [ VGNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CLO and Secretary

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent Rights	(1)	09/18/2026		A		113.023		(1)	(1)	Ordinary Shares	113.023	$0.00	113.023	D

Explanation of Responses:

1. The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares.

	/s/ Janis N. Acosta	09/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)